Management & Regulatory

Will Mehmet Oz Revolutionize Telehealth with New CMS Policies?
Management & Regulatory Will Mehmet Oz Revolutionize Telehealth with New CMS Policies?

The rapid advancements in telehealth have been met with a mixture of enthusiasm and concern, especially as regulatory frameworks struggle to keep pace with technological innovations. At the center of this challenge is Mehmet Oz, the newly appointed Administrator of the Centers for Medicare &

Novartis' Vanrafia Approved by FDA for Rare Kidney Disease Treatment
Management & Regulatory Novartis' Vanrafia Approved by FDA for Rare Kidney Disease Treatment

Ivan Kairatov is a recognized authority in the biopharma sector, with an extensive background in technological advancements and R&D. In this interview, Ivan shares his insights on the new FDA-approved treatment for IgA nephropathy (IgAN), shedding light on its significance in treating this rare

HHS Layoffs and Reorganization Spark Opposition and Legal Action
Management & Regulatory HHS Layoffs and Reorganization Spark Opposition and Legal Action

The U.S. Department of Health and Human Services (HHS) is experiencing a turbulent phase marked by extensive layoffs and a major reorganization under Secretary Robert F. Kennedy Jr. These moves have ignited substantial controversy and legal battles, drawing sharp reactions from various stakeholders

How Is AI Revolutionizing Precision Medicine by 2029?
Management & Regulatory How Is AI Revolutionizing Precision Medicine by 2029?

The dramatic rise in the global AI in precision medicine market projects an impressive 25-30% surge by 2029. This rapid growth stems from numerous factors: breakthroughs in AI technology, escalating demand for personalized healthcare, the proliferation of genomic data, supportive government

FDA vs. EMA: Which Agency Balances Innovation and Safety Better?
Management & Regulatory FDA vs. EMA: Which Agency Balances Innovation and Safety Better?

Innovation thrives at the intersection of regulatory flexibility and robust oversight, especially within the dynamic field of first-in-class drugs. Today, we delve into this critical topic with Ivan Kairatov, a seasoned biopharma expert with extensive experience in research and development. With a

Alberta's $330 Million Investment to Improve Rural Health Facilities
Management & Regulatory Alberta's $330 Million Investment to Improve Rural Health Facilities

Alberta's government is making a substantial commitment to enhancing health infrastructure in rural areas through a $330 million investment over three years. This strategic initiative is designed to ensure that quality health care is accessible to all residents, regardless of their geographic

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later